Huakang Biomedical Holdings Company Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.3950
-0.0050 (-1.25%)
Sep 19, 2025, 2:49 PM HKT
HKG:8622 Market Cap
HKG:8622 has a market cap or net worth of 197.69 million as of September 19, 2025. Its market cap has increased by 117.03% in one year.
Market Cap
197.69M
Enterprise Value
162.02M
Revenue
28.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since December 13, 2018, HKG:8622's market cap has increased from 188.00M to 197.69M, an increase of 5.15%. That is a compound annual growth rate of 0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 197.69M | 163.33% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | 42.80M | -20.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 286.22B |
| JD Health International | 220.42B |
| Hansoh Pharmaceutical Group Company | 211.88B |
| Innovent Biologics | 157.66B |
| WuXi Biologics | 153.53B |
| Sino Biopharmaceutical | 151.30B |
| Akeso | 119.47B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.44B |